Skip to main content

Are you a legal professional? Visit our professional site

Please enter a legal issue and/or a location
Begin typing to search, use arrow keys to navigate, use enter to select

Find a Lawyer

More Options

Cancer Research Tech. Ltd. v. Barr Laboratories, Inc., 10-1204

By FindLaw Staff on November 09, 2010 5:57 PM

Patent infringement suit related to compounds and methods for treating cancer

Cancer Research Tech. Ltd. v. Barr Laboratories, Inc., 10-1204,  concerned a challenge to the district court's judgment finding the '291 patent unenforceable for prosecution laches and inequitable conduct, in a patent infringement suit related to a genus of tetrazine derivative compounds and methods for treating cancer by administering those compounds.

In reversing, the court held that the district court committed legal error in holding the '291 patent unenforceable for prosecution laches in the absence of any evidence of intervening rights.  The court also held that the district court's decision holding the '291 patent unenforceable for inequitable conduct is reversed as the district court committed clear error in finding that plaintiff acted with deceptive intent.

Related Link:

Copied to clipboard